Cancer Survival Study After Heart Inflammation from Immunotherapy
Part of Bones, joints & muscles, Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This research tracks outcomes for cancer patients who developed heart inflammation (myocarditis) while receiving immune checkpoint inhibitor therapy. By studying survival patterns, researchers hope to better understand how to manage this serious side effect and improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been treated with at least one immune checkpoint inhibitor (a type of immunotherapy for cancer)
- You have been diagnosed with myocarditis (inflammation of the heart muscle) that was possibly, probably, or definitely caused by your immunotherapy
- Medical records showing when your myocarditis started are available
- Your medical team can track your health outcomes over time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic factors that may affect the risk of heart inflammation (myocarditis) caused by immune checkpoint inhibitors (ICIs), a type of cancer immunotherapy. It aims to find out if your genes make you more likely to develop this side effect.
This study looks at reports from large health databases to find out if certain cancer drugs (checkpoint inhibitors) cause heart problems. It aims to understand which patients have a higher risk, which may help doctors watch for heart issues in the future.
This study looks for specific markers in the blood that can help doctors better understand and treat heart inflammation (myocarditis) caused by immunotherapy in people with lung cancer. If you join, you will help find ways to improve care for other patients.
This study looks at how to monitor and help patients who have had heart problems as a side effect of cancer immunotherapy. If you have recovered from such a heart issue, this program may support your heart health and overall recovery during and after cancer treatment.
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
This study watches heart health in people starting immunotherapy (a cancer treatment that boosts the immune system) by checking blood samples for heart-related markers. It aims to find early signs of heart problems so they can be managed sooner.
Hear when a new Immune Checkpoint Inhibitor-associated Myocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.